iStent Trabecular Micro-Bypass
iStent® Trabecular Micro-Bypass: Offering New Hope for Glaucoma Patients
Patients suffering from mild-to-moderate open-angle glaucoma now have access to an exciting new treatment option designed to help reduce pressure in the eye and slow the progression of glaucoma. The iStent® Trabecular Micro-Bypass is the smallest medical device ever approved by the FDA. iStent® is designed to create a permanent opening in your trabecular meshwork, and works continuously to improve the outflow of fluid from your eyes to help control eye pressure.
Mild-to-moderate open-angle glaucoma is the most common type of glaucoma, which occurs when pressure in the eye builds to abnormal levels. If the drainage system in the eye is clogged or not working properly, this eye pressure (also known as intraocular pressure) may increase to unhealthy levels, causing damage to the optic nerve. This can result in permanent vision loss. The iStent® implant is meant to slow the progression of glaucoma by improving the eye’s ability to drain excess fluid and reduce the pressure in your eye.
Most people with this type of glaucoma take one, two or even three types of medications daily to control intraocular pressure. Unfortunately, these drops can be inconvenient and expensive. The iStent® may be a blessing, allowing many patients to reduce or possibility eliminate the need for glaucoma medications at the discretion of his or her physician. It is important that patients who receive the iStent® continue to regularly visit his or her eye care professional to monitor the progression of their glaucoma.
Am I a candidate for the iStent® implant?
The iStent® is indicated for use in patients suffering from mild-to-moderate open-angle glaucoma in conjunction with cataract surgery who currently are being treated with ocular hypotensive medication. After scheduling an appointment with one of our world-class ophthalmologists, your doctor can help you determine if you are a good candidate for the iStent®.
Why choose The Eye Institute of Utah for your glaucoma treatment?
Dr. Robert Cionni and Dr. Alan Crandall, of The Eye Institute of Utah, were the first surgeons in the state of Utah to perform surgery using the iStent® implant, outside of clinical trials. This treatment option for glaucoma patients is new and only offered by a select handful of eye surgeons across the country. At The Eye Institute of Utah, we focus on offering the latest technology and treatment options for patients, and continue being involved in the research and development of cutting edge eye care technology.